ES8600751A1 - Procedimiento de producir derivados de acido oxazolacetico. - Google Patents

Procedimiento de producir derivados de acido oxazolacetico.

Info

Publication number
ES8600751A1
ES8600751A1 ES538030A ES538030A ES8600751A1 ES 8600751 A1 ES8600751 A1 ES 8600751A1 ES 538030 A ES538030 A ES 538030A ES 538030 A ES538030 A ES 538030A ES 8600751 A1 ES8600751 A1 ES 8600751A1
Authority
ES
Spain
Prior art keywords
derivatives
acid derivatives
production
compositions containing
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538030A
Other languages
English (en)
Other versions
ES538030A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES538030A0 publication Critical patent/ES538030A0/es
Publication of ES8600751A1 publication Critical patent/ES8600751A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/40—One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO DE PRODUCIR DERIVADOS DE ACIDO OXAZOLACETICO.CONSISTE EN HIDROLIZAR UN COMPUESTO DE FORMULA (II) Y ESTERIFICADO SEGUIDAMENTE PARA OBTENER DERIVADOS DE ACIDO OXAZOLACETICO DE FORMULA (I), DONDE R1 SE ELIGE DEL GRUPO FORMADO POR LA FORMULA (III); R2 ES UN GRUPO ALQUILO DE CADENA RECTA O RAMIFICADA CON C 1 A 6; Y R3 ES H, UN GRUPO ALQUILO DE CADENA RECTA O RAMIFICADA CON C 1 A 6 O UN GRUPO ARALQUILO.SE UTILIZAN FARMACOLOGICAMENTE COMO ANTIDIABETICOS POR MEJORAR LA TOLERANCIA DE LA GLUCOSA Y POSEER ACTIVIDAD DE POTENCIACION DE LA SENSIBILIDAD A LA INSULINA EN ANIMALES MAMIFEROS.
ES538030A 1982-06-15 1984-11-16 Procedimiento de producir derivados de acido oxazolacetico. Expired ES8600751A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57103544A JPS58219169A (ja) 1982-06-15 1982-06-15 オキサゾ−ル酢酸誘導体

Publications (2)

Publication Number Publication Date
ES538030A0 ES538030A0 (es) 1985-11-01
ES8600751A1 true ES8600751A1 (es) 1985-11-01

Family

ID=14356777

Family Applications (2)

Application Number Title Priority Date Filing Date
ES523152A Expired ES8503676A1 (es) 1982-06-15 1983-06-10 Procedimiento de producir derivados de acido oxazolacetico
ES538030A Expired ES8600751A1 (es) 1982-06-15 1984-11-16 Procedimiento de producir derivados de acido oxazolacetico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES523152A Expired ES8503676A1 (es) 1982-06-15 1983-06-10 Procedimiento de producir derivados de acido oxazolacetico

Country Status (15)

Country Link
US (1) US4602027A (es)
EP (1) EP0096890B1 (es)
JP (1) JPS58219169A (es)
KR (1) KR840005116A (es)
AU (1) AU1565783A (es)
CA (1) CA1195986A (es)
DE (1) DE3374685D1 (es)
DK (1) DK272083A (es)
ES (2) ES8503676A1 (es)
FI (1) FI832036A7 (es)
GR (1) GR78290B (es)
HU (1) HU189296B (es)
NO (1) NO832146L (es)
PT (1) PT76871B (es)
ZA (1) ZA834307B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531608D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Treatment
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0409418A1 (en) * 1989-07-20 1991-01-23 Imperial Chemical Industries Plc Heterocyclic tertiary alcohols
EP0440183A1 (en) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Oxazole compounds, their production and use
DE69132006T2 (de) 1990-11-30 2000-08-03 Otsuka Pharmaceutical Co., Ltd. Thiazolederivate als inhibitoren von aktivem sauerstoff
CA2118706A1 (en) * 1992-07-13 1994-01-20 Saizo Shibata Novel thiazolidinedione compounds and use thereof
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
CN1130361C (zh) 1998-03-30 2003-12-10 日本烟草产业株式会社 异噁唑烷二酮化合物的制备方法
JP4815083B2 (ja) * 1999-08-31 2011-11-16 メルク・シャープ・エンド・ドーム・コーポレイション 複素環化合物およびそれの使用方法
KR100459917B1 (ko) * 2001-12-14 2004-12-03 (주)바이오뉴트리젠 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401120A (en) * 1965-10-23 1968-09-10 Gaf Corp Corrosion inhibitors
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres

Also Published As

Publication number Publication date
PT76871B (en) 1986-01-27
AU1565783A (en) 1983-12-22
FI832036A0 (fi) 1983-06-07
ES538030A0 (es) 1985-11-01
DK272083D0 (da) 1983-06-14
GR78290B (es) 1984-09-26
KR840005116A (ko) 1984-11-03
DE3374685D1 (en) 1988-01-07
FI832036L (fi) 1983-12-16
JPH044312B2 (es) 1992-01-27
EP0096890A2 (en) 1983-12-28
HU189296B (en) 1986-06-30
ZA834307B (en) 1984-03-28
US4602027A (en) 1986-07-22
EP0096890B1 (en) 1987-11-25
NO832146L (no) 1983-12-16
EP0096890A3 (en) 1984-11-14
FI832036A7 (fi) 1983-12-16
CA1195986A (en) 1985-10-29
ES523152A0 (es) 1985-04-01
ES8503676A1 (es) 1985-04-01
PT76871A (en) 1983-07-01
JPS58219169A (ja) 1983-12-20
DK272083A (da) 1983-12-16

Similar Documents

Publication Publication Date Title
HUT47578A (en) Process for production of new derivatives of pirasole /3,4-d/-piramidin and medical compositions containing them
ES449162A1 (es) Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
IT7949662A0 (it) Procedimento per la produzione di acido tereftalico da metiltereftala to come prodotto intermedio
ES8600751A1 (es) Procedimiento de producir derivados de acido oxazolacetico.
ES371093A1 (es) Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico.
IL33846A (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
ES8400727A1 (es) "metodo de producir un ester dialilico de acido tetrabromoftalico".
SE8004079L (sv) Nya hydroxiaminoeburnanderivat jemte sett for deras framstellning
GB1432503A (en) Cycloalkylalkylesters and process for their preparation
US3997568A (en) Conversion of (10'S)-zearalenone to (10'R)-zearalanone
ATE56963T1 (de) Verfahren zur herstellung von aminothiazolessigsaeurederivaten.
SE7510787L (sv) Nya kvevehaltiga, polycykliska foreningar, salter derav och deras optiska antipoder, jemte sett for deras framstellning
ES449817A1 (es) Procedimiento para producir 2-fenilamino-tiazolinas susti- tuidas.
SE7601948L (sv) Sett att framstella karboxi-alkan-fosfonsyror och karboxi-alkyl-fosfinsyror
ES8504794A1 (es) Un procedimiento para la preparacion de una quinazolina
FR2446272A1 (fr) Nouveaux derives substitues du penten-2-yle, leur procede de preparation et leur application dans la synthese d'un precurseur de l'acide chrysanthemique
FR2442225A1 (fr) Procede de preparation d'esters basiques d'acides hydroxycyclohexane-carboxyliques substitues
ES450400A1 (es) Un procedimiento para preparar un derivado de acido 7-(ace- tamido, sustituido en alfa)-3-metil-3-cefem-4-carboxilico.
GB2001974A (en) Vincinic acid derivatives and process for the preparation thereof
ES8404345A1 (es) Un procedimiento de preparacion de derivados del acido hidroxi-2-tiofeno-acetico.
GB1298620A (en) Substituted benzopyrans and process for the production thereof
SE7900889L (sv) Sett att framstella xantonderivat
GB1472257A (en) Derivative of 4-hydroxy-5-azacoumarin
ES8104198A1 (es) Un procedimiento para la preparacion de un derivado de mo- noamida del acido tereftalico
ES8506702A1 (es) Un derivado del acido furiloxazolilacetico